COEP
Coeptis Therapeutics Holdings, Inc. - Common Stock (COEP)
$70
About Coeptis Therapeutics Holdings, Inc. - Common Stock (COEP)
Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical company, which engages in developing innovative cell therapy platforms for cancer that can disrupt conventional treatment paradigms and improve patient outcomes. The firm's products include CD38-GEAR-NK, CD38-Diagnostic and GEAR-NK Product. The company was founded in 2017 and is headquartered in Wexford, PA.
Details
Daily high
$11.17
Daily low
$6.26
Price at open
$11.00
52 Week High
$13.70
52 Week Low
$2.31
Market cap
25.9M
Dividend yield
0.00%
Volume
716,978
Avg. volume
65,358
P/E ratio
-1.36
Coeptis Therapeutics Holdings, Inc. - Common Stock News
Details
Daily high
$11.17
Daily low
$6.26
Price at open
$11.00
52 Week High
$13.70
52 Week Low
$2.31
Market cap
25.9M
Dividend yield
0.00%
Volume
716,978
Avg. volume
65,358
P/E ratio
-1.36